Laura L. Mulloy

1.9k total citations
38 papers, 1.3k citations indexed

About

Laura L. Mulloy is a scholar working on Transplantation, Public Health, Environmental and Occupational Health and Family Practice. According to data from OpenAlex, Laura L. Mulloy has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Transplantation, 15 papers in Public Health, Environmental and Occupational Health and 9 papers in Family Practice. Recurrent topics in Laura L. Mulloy's work include Renal Transplantation Outcomes and Treatments (15 papers), Pregnancy and Medication Impact (11 papers) and Medication Adherence and Compliance (9 papers). Laura L. Mulloy is often cited by papers focused on Renal Transplantation Outcomes and Treatments (15 papers), Pregnancy and Medication Impact (11 papers) and Medication Adherence and Compliance (9 papers). Laura L. Mulloy collaborates with scholars based in United States, France and Switzerland. Laura L. Mulloy's co-authors include Marie A. Chisholm, Joseph T. DiPiro, Charles E. Lance, Gail M. Williamson, J. D. Wynn, Muralidharan Jagadeesan, William E. Wade, Christina A. Spivey, Teri Browne and Jennifer C. Gander and has published in prestigious journals such as The FASEB Journal, Journal of the American Society of Nephrology and Journal of the American Geriatrics Society.

In The Last Decade

Laura L. Mulloy

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura L. Mulloy United States 20 689 347 333 273 258 38 1.3k
Robert T. Schweizer United States 18 453 0.7× 409 1.2× 158 0.5× 164 0.6× 174 0.7× 56 1.4k
Stanley A. Bartus United States 12 377 0.5× 313 0.9× 158 0.5× 157 0.6× 145 0.6× 32 956
H. Vlaminck Belgium 7 526 0.8× 299 0.9× 281 0.8× 262 1.0× 174 0.7× 13 1.0k
Lut Berben Switzerland 15 400 0.6× 232 0.7× 365 1.1× 204 0.7× 127 0.5× 35 1.0k
Brett Pinsky United States 18 656 1.0× 250 0.7× 205 0.6× 291 1.1× 142 0.6× 35 1.3k
James N. Fleming United States 17 355 0.5× 161 0.5× 99 0.3× 98 0.4× 130 0.5× 59 730
Sandra Amaral United States 22 899 1.3× 652 1.9× 61 0.2× 129 0.5× 298 1.2× 96 1.7k
Rebecca P. Winsett United States 17 399 0.6× 248 0.7× 74 0.2× 124 0.5× 105 0.4× 59 983
Lianne Barnieh Canada 22 220 0.3× 533 1.5× 57 0.2× 50 0.2× 95 0.4× 58 1.4k
Comfort Mshelia United Kingdom 6 39 0.1× 79 0.2× 1.1k 3.2× 369 1.4× 318 1.2× 8 1.6k

Countries citing papers authored by Laura L. Mulloy

Since Specialization
Citations

This map shows the geographic impact of Laura L. Mulloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura L. Mulloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura L. Mulloy more than expected).

Fields of papers citing papers by Laura L. Mulloy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura L. Mulloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura L. Mulloy. The network helps show where Laura L. Mulloy may publish in the future.

Co-authorship network of co-authors of Laura L. Mulloy

This figure shows the co-authorship network connecting the top 25 collaborators of Laura L. Mulloy. A scholar is included among the top collaborators of Laura L. Mulloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura L. Mulloy. Laura L. Mulloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mulloy, Laura L., et al.. (2024). New onset diabetic ketoacidosis in a renal transplant recipient. The American Journal of the Medical Sciences. 369(5). 630–633.
2.
Gani, Imran, et al.. (2023). IL-10-producing memory B regulatory cells as a novel target for HLA-G to prolong human kidney allograft survival. Human Immunology. 84(8). 366–373. 3 indexed citations
3.
Mulloy, Laura L., et al.. (2021). Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation. Frontiers in Immunology. 12. 687715–687715. 15 indexed citations
4.
Portik‐Dobos, Vera, et al.. (2020). HLA-G and humanized mouse models as a novel therapeutic approach in transplantation. Human Immunology. 81(4). 178–185. 8 indexed citations
5.
6.
Portik‐Dobos, Vera, et al.. (2016). Mouse models for studies of HLA-G functions in basic science and pre-clinical research. Human Immunology. 77(9). 711–719. 8 indexed citations
7.
Wu, Juan, et al.. (2009). Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance. Human Immunology. 70(12). 988–994. 8 indexed citations
8.
Chisholm, Marie A., Gail M. Williamson, Charles E. Lance, & Laura L. Mulloy. (2007). Predicting adherence to immunosuppressant therapy: a prospective analysis of the theory of planned behaviour. Nephrology Dialysis Transplantation. 22(8). 2339–2348. 66 indexed citations
9.
Chisholm, Marie A., et al.. (2007). Is Age Associated with the Number or Types of Medications Prescribed to Renal Transplant Recipients?. Journal of the American Geriatrics Society. 55(3). 389–394. 4 indexed citations
10.
Prisant, L. Michael, Harold M. Szerlip, & Laura L. Mulloy. (2006). Fibromuscular Dysplasia: An Uncommon Cause of Secondary Hypertension. Journal of Clinical Hypertension. 8(12). 894–898. 6 indexed citations
11.
Chisholm, Marie A., Charles E. Lance, Gail M. Williamson, & Laura L. Mulloy. (2005). Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Education and Counseling. 59(1). 13–20. 86 indexed citations
12.
Chisholm, Marie A., Charles E. Lance, Gail M. Williamson, & Laura L. Mulloy. (2004). Development and validation of an immunosuppressant therapy adherence barrier instrument. Nephrology Dialysis Transplantation. 20(1). 181–188. 60 indexed citations
13.
Prisant, L. Michael, et al.. (2003). Scleroderma Renal Crisis. Journal of Clinical Hypertension. 5(2). 168–176. 2 indexed citations
14.
Chisholm, Marie A., et al.. (2001). Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications. Clinical Transplantation. 15(5). 330–336. 141 indexed citations
15.
Chisholm, Marie A., Laura L. Mulloy, Muralidharan Jagadeesan, et al.. (2000). RENAL TRANSPLANT PATIENT COMPLIANCE WITH FREE IMMUNOSUPPRESSIVE MEDICATIONS1. Transplantation. 70(8). 1240–1244. 113 indexed citations
16.
Chisholm, Marie A., et al.. (2000). Cost‐benefit analysis of a clinical pharmacist‐managed medication assistance program in a renal transplant clinic. Clinical Transplantation. 14(4). 304–307. 35 indexed citations
17.
Kovarik, John M., Barry D. Kahan, P. R. Rajagopalan, et al.. (1999). POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS FOR BASILIXIMAB IN KIDNEY TRANSPLANTATION. Transplantation. 68(9). 1288–1294. 63 indexed citations
18.
Mulloy, Laura L., et al.. (1998). Basiliximab (Simulect???) Reduces Acute Cellular Rejection In Renal Allografts From Cadaveric And Living Donors. Transplantation. 65(12). S190–S190. 3 indexed citations
19.
Mulloy, Anthony L., Laura L. Mulloy, & Robert S. Weinstein. (1992). Hypercalcemia Due to Hard Water Used for Home Hemodialysis. Southern Medical Journal. 85(11). 1131–1133. 3 indexed citations
20.
Mulloy, Laura L., et al.. (1991). Polymicrobial bacteremia during long-term hemodialysis.. PubMed. 84(5). 594–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert T. Schweizer Breakdown of academic impact, for papers by Stanley A. Bartus Breakdown of academic impact, for papers by H. Vlaminck Breakdown of academic impact, for papers by Lut Berben Breakdown of academic impact, for papers by Brett Pinsky Breakdown of academic impact, for papers by James N. Fleming Breakdown of academic impact, for papers by Sandra Amaral Breakdown of academic impact, for papers by Rebecca P. Winsett Breakdown of academic impact, for papers by Lianne Barnieh Breakdown of academic impact, for papers by Comfort Mshelia
Rankless by CCL
2026